Lantern Pharma Inc. Cost, Amortization
Lantern Pharma Inc. (LTRN) reported Cost, Amortization of $13.26 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-01.
Discontinued › Expense Statement
us-gaap:CostOfGoodsAndServicesSoldAmortization · last filed 2021-11-01
- Lantern Pharma Inc. cost, amortization for the quarter ending 2021-09-30 was -$5.03M.
| Period end | Cost, Amortization 3 month | Cost, Amortization 6 month | Cost, Amortization 9 month |
|---|---|---|---|
| 2021-09-30 | -$5.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $13.26M 10-Q · filed 2021-11-01 | |
| 2021-06-30 | $18.28M 10-Q · filed 2021-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |